Are functional erythropoietin receptors present in cancer cells?
- Book ID
- 120847221
- Publisher
- Adis International Limited (now part of Wolters Kluwer Health)
- Year
- 2007
- Weight
- 154 KB
- Volume
- &NA;
- Category
- Article
- ISSN
- 1173-8324
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Previously, GRP receptors were characterized in small cell lung cancer cells and here non-small cell lung cancer (NSCLC) cells were investigated: (1251-Tyr4) bombesin (BN) or lZ51-GRP bound with high affinity to NCLH720 (lung carcinoid) and NCI-HI 299 (large cell carcinoma) cells. Binding was specif
## Abstract Erythropoietin (Epo) therapy reduces red cell transfusion requirements and improves the quality of life of anemic cancer patients receiving chemotherapy. However, there is concern that Epo may promote tumor growth. We investigated by realβtime RTβPCR, immunofluorescence microscopy, West
## Abstract The identification of erythropoietin receptors (EpoR) on cancer cells has caused concern, since it implies the possibility that treatment of cancer patients with erythropoietin (Epo) and related agents with demonstrable antiapoptotic activity could enhance cancer growth and progression.